Today: Today, Allscripts Healthcare Solutions Inc. (MDRX) Receives Consensus Recommendation of “Hold” from Analysts

Today, Allscripts Healthcare Solutions Inc. (MDRX) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have earned a consensus rating of “Hold” from the twenty brokerages that are covering the firm. Eleven research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price target among brokers that have covered the stock in the last year is $15.31.

A number of analysts recently weighed in on the company. JPMorgan Chase & Co. assumed coverage on Allscripts Healthcare Solutions in a research report on Sunday, October 30th. They issued a “buy” rating and a $15.00 target price for the company. Canaccord Genuity set a $17.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Saturday, November 19th. Piper Jaffray Cos. reaffirmed a “neutral” rating and issued a $15.00 price target (up from $12.00) on shares of Allscripts Healthcare Solutions in a research note on Monday, August 8th. Zacks Investment Research raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $16.00 price target on the stock in a research note on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. lifted their price target on Allscripts Healthcare Solutions from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Friday, August 5th.

In other Allscripts Healthcare Solutions news, CEO Paul Black sold 15,000 shares of the stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $13.00, for a total value of $195,000.00. Following the transaction, the chief executive officer now owns 1,177,009 shares of the company’s stock, valued at $15,301,117. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP James Hewitt sold 17,500 shares of the stock in a transaction dated Thursday, September 15th. The shares were sold at an average price of $13.00, for a total value of $227,500.00. Following the completion of the transaction, the senior vice president now directly owns 158,104 shares in the company, valued at approximately $2,055,352. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of MDRX. Nuveen Asset Management LLC increased its position in Allscripts Healthcare Solutions by 82.1% in the first quarter. Nuveen Asset Management LLC now owns 139,737 shares of the company’s stock worth $1,846,000 after buying an additional 63,000 shares in the last quarter. Seven Eight Capital LLC purchased a new position in Allscripts Healthcare Solutions during the first quarter worth $102,000. Teacher Retirement System of Texas increased its position in Allscripts Healthcare Solutions by 13.8% in the second quarter. Teacher Retirement System of Texas now owns 25,127 shares of the company’s stock worth $319,000 after buying an additional 3,041 shares in the last quarter. First Quadrant L P CA increased its position in Allscripts Healthcare Solutions by 473.4% in the second quarter. First Quadrant L P CA now owns 71,100 shares of the company’s stock worth $903,000 after buying an additional 58,700 shares in the last quarter. Finally, Fox Run Management L.L.C. purchased a new position in Allscripts Healthcare Solutions during the second quarter worth $182,000.

Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up 0.27% during trading on Friday, hitting $11.19. The company’s stock had a trading volume of 785,719 shares. The firm has a 50 day moving average of $11.82 and a 200 day moving average of $12.86. The firm’s market cap is $2.07 billion. Allscripts Healthcare Solutions has a 12 month low of $9.80 and a 12 month high of $15.78.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, November 3rd. The company reported $0.14 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.01. The firm earned $392.40 million during the quarter, compared to the consensus estimate of $414.92 million. Allscripts Healthcare Solutions had a positive return on equity of 5.79% and a negative net margin of 0.14%. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 EPS. Equities research analysts predict that Allscripts Healthcare Solutions will post $0.56 earnings per share for the current year.

Related posts

Leave a Comment